Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland
Abstract
:1. Introduction
2. Materials and Methods
2.1. Google Trends Data
2.2. Pilot Exploration of the Trends
2.3. Region-Specific “Dictionaries” of the Most Popular Psychedelics
2.4. Statistical Analysis and Ethics
3. Results
4. Discussion
4.1. Study Limitations
4.2. Future Research
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Tracy, D.K.; Wood, D.M.; Baumeister, D. Novel psychoactive substances: Types, mechanisms of action, and effects. Br. Med. J. 2017, 356, i6848. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dargan, P.; Wood, D. Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, 2nd ed.; Academic Press: London, UK, 2021; ISBN 9780128187883. [Google Scholar]
- Al-Imam, A. Monitoring and Analysis of Novel Psychoactive Substances in Trends Databases, Surface Web and the Deep Web, with Special Interest and Geo-Mapping of the Middle East. Master’s Thesis, University of Hertfordshire, Hatfield, UK, 2017. [Google Scholar] [CrossRef]
- Pottie, E.; Dedecker, P.; Stove, C.P. Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of β-arrestin 2 and miniGαq bioassays. Biochem. Pharmacol. 2020, 182, 114251. [Google Scholar] [CrossRef] [PubMed]
- Kettner, H.; Mason, N.L.; Kuypers, K.P. Motives for classical and novel psychoactive substances use in psychedelic polydrug users. Contemp. Drug Probl. 2019, 46, 304–320. [Google Scholar] [CrossRef]
- Langlitz, N. Pharmacovigilance and post-black market surveillance. Soc. Stud. Sci. 2009, 39, 395–420. [Google Scholar] [CrossRef]
- Alomar, M.; Palaian, S.; Al-Tabakha, M.M. Pharmacovigilance in perspective: Drug withdrawals, data mining and policy implications. F1000Research 2019, 8, 2109. [Google Scholar] [CrossRef] [Green Version]
- Nichols, D.E. Psychedelics. Pharmacol. Rev. 2016, 68, 264–355. [Google Scholar] [CrossRef] [Green Version]
- Johnson, E.J.; Moe, W.W.; Fader, P.S.; Bellman, S.; Lohse, G.L. On the depth and dynamics of online search behavior. Manag. Sci. 2004, 50, 299–308. [Google Scholar] [CrossRef] [Green Version]
- Nichols, D.E.; Walter, H. The history of psychedelics in psychiatry. Pharmacopsychiatry 2021, 54, 151–166. [Google Scholar] [CrossRef]
- Yaden, D.B.; Yaden, M.E.; Griffiths, R.R. Psychedelics in psychiatry—keeping the renaissance from going off the rails. JAMA Psychiatry 2021, 78, 469–470. [Google Scholar] [CrossRef]
- Nutt, D.; Carhart-Harris, R. The current status of psychedelics in psychiatry. JAMA Psychiatry 2021, 78, 121–122. [Google Scholar] [CrossRef]
- McClure-Begley, T.D.; Roth, B.L. The promises and perils of psychedelic pharmacology for psychiatry. Nat. Rev. Drug Discov. 2022, 21, 463–473. [Google Scholar] [CrossRef] [PubMed]
- Chramast, J.; Dąbkowska, M.; Jabłońska, M.; Macander, D.; Pietrzak, S.; Sieniawska, A.; Wodowski, G. Lokalne Strategie Rozwiązywania Problemu Narkomanii [Local Strategies for Dealing with Drug Addiction]; Ministerstwo Zdrowia/Krajowe Biuro ds. Przeciwdziałania Narkomanii: Warszawa, Poland, 2018; ISBN 978-83-951463-0-5. [Google Scholar]
- Raport o Stanie Narkomanii w Polsce 2020 [Report on the State of Drug Addiction in Poland 2020]; Krajowe Biuro do Spraw Zapobiegania Narkomanii: Warszawa, Poland, 2020; ISBN 978-83-959842-6-6.
- Gandy, S. Psychedelics and potential benefits in “healthy normal”: A review of the literature. J. Psychedelic Stud. 2019, 3, 280–287. [Google Scholar] [CrossRef]
- Eastman, C.M.; Jansen, B.J. Coverage, relevance, and ranking: The impact of query operators on Web search engine results. ACM Trans. Inf. Syst. 2003, 21, 383–411. [Google Scholar] [CrossRef]
- Nuti, S.V.; Wayda, B.; Ranasinghe, I.; Wang, S.; Dreyer, R.P.; Chen, S.I.; Murugiah, K. The use of google trends in health care research: A systematic review. PLoS ONE 2014, 9, e109583. [Google Scholar] [CrossRef] [Green Version]
- Carneiro, H.A.; Mylonakis, E. Google trends: A web-based tool for real-time surveillance of disease outbreaks. Clin. Infect. Dis. 2009, 49, 1557–1564. [Google Scholar] [CrossRef]
- Catalani, V.; Corkery, J.M.; Guirguis, A.; Napoletano, F.; Arillotta, D.; Zangani, C.; Vento, A.; Schifano, F. Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise. Eur. Neuropsychopharmacol. 2021, 49, 69–92. [Google Scholar] [CrossRef]
- Erowid: Documenting the Complex Relation between Humans & Psychoactives. 1995. Available online: https://erowid.org/splash.php (accessed on 7 December 2021).
- Drugs-Forum: Addiction Help & Harm reduction. 2010. Available online: https://drugs-forum.com/ (accessed on 7 December 2021).
- Alcohol and Drug Foundation. Psychedelics. 2021. Available online: https://adf.org.au/drug-facts/psychedelics/ (accessed on 7 December 2021).
- National Institutes of Health: National Institute on Drug Abuse. Common Hallucinogens and Dissociative Drugs. 2015. Available online: https://nida.nih.gov/publications/research-reports/hallucinogens-dissociative-drugs/what-are-dissociative-drugs (accessed on 7 December 2021).
- United Nations Office on Drugs and Crime. World Drug Report 2019. 2019. Available online: https://wdr.unodc.org/wdr2019/ (accessed on 12 January 2021).
- Gelper, S.; Fried, R.; Croux, C. Robust forecasting with exponential and Holt–Winters smoothing. J. Forecast. 2010, 29, 285–300. [Google Scholar] [CrossRef] [Green Version]
- Kasper-Pakosz, R.; Pietras, M.; Łuczaj, Ł. Wild and native plants and mushrooms sold in the open-air markets of south-eastern Poland. J. Ethnobiol. Ethnomed. 2016, 12, 45. [Google Scholar] [CrossRef] [Green Version]
- Mushroom Picking. Discover Poland. 2022. Available online: https://discoverpoland.travel (accessed on 3 March 2022).
- Mętrak, N. Why Are Poles So Obsessed with Mushroom Picking? 2018. Available online: https://culture.pl/en (accessed on 3 March 2022).
- Motyka, M.A. Uwarunkowania narkomanii młodzieży: Zagrożenia w internecie [Determinants of youth drug use: Threats on the Internet]. In Człowiek—Społeczeństwo—Bezpieczeństwo: Wybrane Aspekty [Man—Society—Security: Selected Aspects]; Gitling, M., Wojaczek, I., Eds.; Instytut Socjologii PWSW: Przemyśl, Poland, 2018; Available online: https://rzeszow.academia.edu/MarekAMotyka/Chapters (accessed on 12 March 2022).
- Kurzępa, J.; Jędrzejko, M.Z.; Motyka, M.A.; Zagajewski, T.; Zagajewski, T.; Białas, T. Diagnoza Problemu Używania Narkotyków i Nowych Środków Psychoaktywnych na Terenie Województwa Łódzkiego [Diagnosis of the Problem of use of Drugs and New Psychoactive Substances in the Łódzkie Region]; CBRD/Oficyna Wyd. Von Velke Centrum Profilaktyki Społecznej: Łódź/Milanowek, Poland, 2019; ISBN 978-83-939410-1-8. [Google Scholar]
- Barczuk, K. Nowe narkotyki w praktyce służb Państwowej Inspekcji Sanitarnej—Ujęcie przekrojowe [New drugs in the practice of the State Sanitary Inspection—A cross-sectional approach]. In Nowe Narkotyki w Polsce: Tendencje, Zagrożenia, Procedury postepowania [New Drugs in Poland: Trends, Threats, Procedures]; Waluk, E., Ed.; GIS: Warszawa, Poland, 2016; ISBN 978-83-954638-1-5. [Google Scholar]
- Herian, M.; Wojtas, A.; Kamińska, K.; Świt, P.; Wach, A.; Gołembiowska, K. Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats. Neurotox. Res. 2019, 36, 91–100. [Google Scholar] [CrossRef] [Green Version]
- Zawilska, J.B.; Kacela, M.; Adamowicz, P. NBOMes-Highly Potent and Toxic Alternatives of LSD. Front. Neurosci. 2020, 14, 78. [Google Scholar] [CrossRef] [Green Version]
- Elbardisy, H.M.; Foster, C.W.; Marron, J.; Mewis, R.E.; Sutcliffe, O.B.; Belal, T.S.; Talaat, W.; Daabees, H.G.; Banks, C.E. Quick Test for Determination of N-Bombs (Phenethylamine Derivatives, NBOMe) Using High-Performance Liquid Chromatography: A Comparison between Photodiode Array and Amperometric Detection. ACS Omega 2019, 4, 14439–14450. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Czerner, A.; Parzych, D.; Piejko, M.; Wanke, M. Alternatywny Dyskurs o Substancjach Psychoaktywnych na Podstawie Analizy Forum Internetowego Hyperreal [Alternative Discourse on Psychoactive Substances Based on Analysis of the Hyperreal Online Forum]; PRO: Opole, Poland, 2014. Available online: https://www.cinn.gov.pl/portal?id=166447 (accessed on 17 March 2022).
- Więckiewicz, G.; Pudlo, R. Nowe substancje psychoaktywne w Polsce—Co lekarz powinien wiedzieć w 2019 roku? [New psychoactive substances in Poland—What your doctor should know in 2019]. Psychiatria 2019, 16, 227–232. [Google Scholar]
- Diagnoza Społeczna 2015 [Social Diagnosis 2015] Diagnoza Społeczna. 2015. Available online: http://www.diagnoza.com/pliki/raporty/Diagnoza_raport_2015.pdf (accessed on 15 March 2022).
- Wieckiewicz, G.; Pudlo, R. Wyniki ogólnopolskiej ankiety “PolDrugs 2021”: Kim są Polscy Użytkownicy Substancji Psychoaktywnych? [Results of the Nationwide Survey “PolDrugs 2021”: Polish Users of Psychoactive Substances, Who Are They?]. Psychiatry 2021, 18, 119–128. [Google Scholar] [CrossRef]
- Bijoch, Ł.; Pękała, M.; Beroun, A. Molecular basis of the action of selected psychoactive substances. Adv. Biochem. 2021, 67, 141–156. [Google Scholar] [CrossRef]
- Hutten, N.R.; Mason, N.L.; Dolder, P.C.; Kuypers, K.P. Motives and side-effects of microdosing with psychedelics among users. Int. J. Neuropsychopharmacol. 2019, 22, 426–434. [Google Scholar] [CrossRef] [Green Version]
- Farrow, S.C.; Kamileen, M.O.; Caputi, L.; Bussey, K.; Mundy, J.E.; McAtee, R.C.; Stephenson, C.R.; O’Connor, S.E. Biosynthesis of an anti-addiction agent from the iboga plant. J. Am. Chem. Soc. 2019, 141, 12979–12983. [Google Scholar] [CrossRef] [Green Version]
- Vilca, L.W.; Gonzales, R.D.; Pariona-Millán, V.; Caycho-Rodríguez, T.; White, M. Development and Validation of the Social Anomie Brief Scale (SAS-10) Against the New Standards Implemented during the COVID-19 Pandemic. Electron. J. Gen. Med. 2022, 19, em375. [Google Scholar] [CrossRef]
- Muhammad, F.I.; Zebari, T.H. Factor of Social Anomie according to Merton’s theory. Zanco J. Humanit. Sci. 2019, 23, 199–211. [Google Scholar]
- Romania, V. Interactional Anomie? Imaging Social Distance after COVID-19: A Goffmanian Perspective. Sociologica 2020, 14, 51–66. [Google Scholar] [CrossRef]
- Mishra Ch Rath, N. Social solidarity during a pandemic: Through and beyond Durkheimian Lens. Soc. Sci. Humanit. Open 2020, 2, 100079. [Google Scholar] [CrossRef]
- Xiong, J.; Lipsitz, O.; Nasri, F.; Lui, L.M.W.; Gill, H.; Phan, L.; Chen-Li, D.; Iacobucci, M.; Ho, R.; Majeed, A.; et al. Impact of COVID-19 pandemic on mental health in the general population: A systematic review. J. Affect. Disord. 2020, 277, 55–64. [Google Scholar] [CrossRef] [PubMed]
- Długosz, P. Trauma COVID-19 w polskich metropoliach—Przypadek Krakowa [The trauma of COVID-19 in Polish metropolises—A case study of Kraków]. Kult. Eduk. 2021, 3, 24–49. [Google Scholar] [CrossRef]
- Fournier, A.; Laurent, A.; Lheureux, F.; Ribeiro-Marthoud, M.A.; Ecarnot, F.; Binquet, C.; Quenot, J.P. Impact of the COVID-19 pandemic on the mental health of professionals in 77 hospitals in France. PLoS ONE 2022, 17, e0263666. [Google Scholar] [CrossRef] [PubMed]
- Motyka, M.A.; Al-Imam, A.; Aljarshawi, M.H.A. SARS-CoV-2 pandemic as an anomie. Przestrz. Społeczna (Soc. Space) 2020, 20, 111–144. [Google Scholar] [CrossRef]
- Roblain, A.; Gale, J.; Abboud, S.; Arnal, C.; Bornand, T.; Hanioti, M.; Klein, O.; Klein, P.P.L.E.; Lastrego, S.; Licata, L.; et al. Social control and solidarity during the COVID-19 pandemic: The direct and indirect effects of causal attribution of insufficient compliance through perceived anomie. J. Community Appl. Soc. Psychol. 2022, 1–11. [Google Scholar] [CrossRef]
- Serafim, A.P.; Durães, R.S.; Rocca, C.C.; Gonçalves, P.D.; Saffi, F.; Cappellozza, A.; Paulino, M.; Dumas-Diniz, R.; Brissos, S.; Brites, R.; et al. Exploratory study on the psychological impact of COVID-19 on the general Brazilian population. PLoS ONE 2021, 16, e0245868. [Google Scholar] [CrossRef]
- United Nations Office on Drugs and Crime. World Drug Report 2021. 2021. Available online: https://www.unodc.org/unodc/en/data-and-analysis/wdr2021.html (accessed on 8 February 2021).
- Evens, R.; Reiche, S.; Marek, R.M.; Moon, D.U.; Groß, R.E.; Romanello, A.; Jalilzadeh Masah, D.; Scicchitano Böckheler, M.; Gutwinski, S.; Montag, C.; et al. Psychedelic experiences during the early COVID-19 pandemic: Findings from an international online survey. Front. Psychiatry 2021, 12, 1850. [Google Scholar] [CrossRef]
- Bonsaksen, T.; Ekeberg, Ø.; Schou-Bredal, I.; Skogstad, L.; Heir, T.; Grimholt, T.K. Use of alcohol and addictive drugs during the COVID-19 outbreak in Norway: Associations with mental health and pandemic-related problems. Front. Public Health 2021, 9, 429. [Google Scholar] [CrossRef]
- Drozdowski, R.; Frąckowiak, M.; Krajewski, M.; Kubacka, M.; Luczys, P.; Modrzyk, A.; Rogowski, Ł.; Rura, P.; Stamm, A. Życie Codzienne w Czasach Pandemii [Daily Life in Times of Pandemic]; UAM: Poznań, Poland, 2020; ISBN 978-83-957630-1-4. [Google Scholar]
- EMCDDA Special Report: COVID-19 and Drugs—Drug Supply via Darknet Markets. 2020. Available online: https://www.emcdda.europa.eu/event/2020/05/emcdda-special-report-covid-19-and-drugs-%E2%80%93-drug-supply-darknet-markets_en (accessed on 5 March 2022).
- Groshkova, T.; Stoian, T.; Cunningham, A.; Griffiths, P.; Singleton, N.; Sedefov, R. Will the Current COVID-19 Pandemic Impact on Long-term Cannabis Buying Practices? J. Addict. Med. 2020, 14, e13-0. [Google Scholar] [CrossRef]
- Young, S.D.; Zheng, K.; Chu, L.F.; Humphreys, K. Internet searches for opioids predict future emergency department heroin admissions. Drug Alcohol Depend. 2018, 190, 166–169. [Google Scholar] [CrossRef]
- Zaami, S.; Marinelli, E.; Varì, M.R. New trends of substance abuse during COVID-19 pandemic: An international perspective. Front. Psychiatry 2020, 11, 700. [Google Scholar] [CrossRef] [PubMed]
- Scherbaum, N.; Bonnet, U.; Hafermann, H.; Schifano, F.; Bender, S.; Grigoleit, T.; Kuhn, J.; Nyhuis, P.; Preuss, U.W.; Reymann, G.; et al. Availability of illegal drugs during the COVID-19 pandemic in western Germany. Front. Psychiatry 2021, 12, 648273. [Google Scholar] [CrossRef] [PubMed]
- European Drug Report 2021. 2021. Available online: https://www.emcdda.europa.eu/edr2021_en (accessed on 11 March 2022).
- Motyka, M.A.; Marcinkowski, J.T. Nowe metody odurzania się. Cz. III. Roślinne halucynogeny: Bieluń i ayahuasca [New methods of intoxication. Part III. Hallucinogens plants: Jimsonweed and ayahuasca]. Probl. Hig. Epidemiol. 2014, 4, 806–815. [Google Scholar]
- Węcławiak, A. Substancje odurzające w kulturze rdzennych plemion Ameryki a ich percepcja w świecie Zachodu [Narcotics in the culture of Native American tribes and their perception in the Western world]. In W Obliczu Zmian. Polityka Narkotykowa w Perspektywie Interdyscyplinarnej [Facing Change. Drug Policy in an Interdisciplinary Perspective]; Kender-Jeziorska, I., Tublewicz, P., Eds.; Społeczna Inicjatywa Narkopolityki: Warszawa, Poland, 2018; Available online: https://sin.org.pl/wp-content/uploads/2018/06/W_obliczu_zmian-SIN-2018.pdf (accessed on 11 March 2022).
- Motyka, M.A.; Al-Imam, A. Representations of psychoactive drugs’ use in mass culture and their impact on audiences. Int. J. Environ. Res. Public Health 2021, 18, 6000. [Google Scholar] [CrossRef] [PubMed]
- Malczewski, A. Skala zjawiska używania narkotyków i “dopalaczy” oraz związane z nimi problemy. [The scale of the phenomenon of drug and “legal high” use and the problems associated with it]. Serwis Inf. Uzależnienia 2021, 4, 42–47. [Google Scholar]
- Motyka, M.A.; Al-Imam, A. Causes of Drug Initiation among Adolescents. Can. J. Fam. Youth (J. Can. Fam. Jeun.) 2022, 14, 63–81. [Google Scholar] [CrossRef]
- Motyka, M.A.; Al-Imam, A. Musical preference and drug use among youth: An empirical study. Res. Adv. Psychiatry 2019, 6, 50–57. [Google Scholar]
- Al-Imam, A.; Lami, F. One Ultimate Journey? AKA the Huxley’s Method: Perspectives of (Ab)Users of Hallucinogens and Entheogens on Having Planned Pre-Mortem Psychedelic Trip. Mod. Appl. Sci. 2019, 13, 13–22. [Google Scholar] [CrossRef]
- Al-Imam, A.; AbdulMajeed, B.A. Do (Ab) Users of Psychedelics Have Tendencies to Abuse High Authority? An Internet Snapshot Study. Glob. J. Health Sci. 2017, 9, 148–155. [Google Scholar] [CrossRef] [Green Version]
- Otiashvili, D.; Mgebrishvili, T.; Beselia, A.; Vardanashvili, I.; Dumchev, K.; Kiriazova, T.; Kirtadze, I. The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: Results of a mixed methods prospective cohort study. Harm Reduct. J. 2022, 19, 25. [Google Scholar] [CrossRef]
- Bergeron, A.; Décary-Hétu, D.; Giommoni, L.; Villeneuve-Dubuc, M.P. The success rate of online illicit drug transactions during a global pandemic. Int. J. Drug Policy 2022, 99, 103452. [Google Scholar] [CrossRef] [PubMed]
- Arillotta, D.; Guirguis, A.; Corkery, J.M.; Scherbaum, N.; Schifano, F. COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis. Brain Sci. 2021, 11, 907. [Google Scholar] [CrossRef] [PubMed]
- Bolinski, R.S.; Walters, S.; Salisbury-Afshar, E.; Ouellet, L.J.; Jenkins, W.D.; Almirol, E.; Van Ham, B.; Fletcher, S.; Johnson, C.; Schneider, J.A.; et al. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings. Int. J. Environ. Res. Public Health 2022, 19, 2230. [Google Scholar] [CrossRef] [PubMed]
- McKeague, J.; Curran, K. Detecting the use of anonymous proxies. Int. J. Digit. Crime Forensics 2018, 10, 74–94. [Google Scholar] [CrossRef] [Green Version]
- Dutta, N.; Jadav, N.; Tanwar, S.; Sarma, H.; Pricop, E. TOR—The Onion Router. In Cyber Security: Issues and Current Trends Studies in Computational Intelligence [Internet]; Springer: Singapore, 2022; pp. 37–55. [Google Scholar] [CrossRef]
- Dong, F. Controlling the internet in China: The real story. Convergence 2012, 18, 403–425. [Google Scholar] [CrossRef]
- Arora, V.S.; McKee, M.; Stuckler, D. Google Trends: Opportunities and limitations in health and health policy research. Health Policy 2019, 123, 338–341. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Psychedelic | OPP | Df | MAE | Level | Trend | Seasonality | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Estimate | SE | p-Value | Estimate | SE | p-Value | Estimate | SE | p-Value | ||||
NBOMe | 13 | 244 | 4.629 | 0.321 | 0.056 | <0.0001 | <0.001 | <0.001 | 0.9232 | 0.386 | 0.066 | <0.0001 |
Cannabis | 19 | 238 | 8.187 | 0.137 | 0.053 | 0.0097 | 0.000 | 0.017 | 1.0000 | 0.179 | 0.080 | 0.0267 |
LSD | 27 | 230 | 14.989 | 0.054 | 0.027 | 0.0446 | 0.005 | 0.026 | 0.8582 | 0.194 | 0.086 | 0.0255 |
Phencyclidine | 14 | 243 | 14.270 | 0.074 | 0.030 | 0.0157 | 0.000 | 0.000 | 0.8122 | 0.137 | 0.063 | 0.0321 |
Psilocybin | 49 | 208 | 17.360 | 0.003 | 0.007 | 0.6822 | 0.251 | 0.625 | 0.6881 | 0.322 | 0.127 | 0.0120 |
Ayahuasca | 52 | 205 | 23.703 | 0.054 | 0.030 | 0.0740 | 0.002 | 0.016 | 0.8957 | 0.414 | 0.113 | 0.0003 |
DOB | 24 | 233 | 22.137 | 0.053 | 0.022 | 0.0180 | 0.001 | 0.001 | 0.6539 | 0.194 | 0.081 | 0.0169 |
DXM | 28 | 229 | 18.544 | 0.032 | 0.036 | 0.3800 | 0.018 | 0.021 | 0.3830 | 0.221 | 0.079 | 0.0056 |
Ergine | 14 | 243 | 17.340 | 0.032 | 0.023 | 0.1661 | 0.012 | 0.031 | 0.7096 | 0.139 | 0.060 | 0.0208 |
Salvinorin A | 10 | 247 | 16.506 | 0.001 | 0.001 | 0.5192 | 0.992 | 1.447 | 0.4937 | 0.108 | 0.048 | 0.0247 |
Dronabinol | 17 | 240 | 16.930 | 0.019 | 0.032 | 0.5499 | <0.001 | 0.031 | 1.0000 | 0.172 | 0.058 | 0.0032 |
AL-LAD | 24 | 233 | 9.879 | 0.016 | 0.017 | 0.3760 | 0.007 | 0.015 | 0.6222 | 0.232 | 0.066 | 0.0004 |
DMT | n/a | |||||||||||
MDMA | ||||||||||||
Ketamine | ||||||||||||
Mescaline | ||||||||||||
Methamphet. | ||||||||||||
Ibogaine | ||||||||||||
2C-B-FLY | ||||||||||||
Nabilone |
Psychedelic Substance | Coefficient | p-Value * |
---|---|---|
NBOMe | 0.1327 | <0.001 |
Cannabis | −0.0053 | 0.895 |
DMT | 0.0292 | 0.497 |
LSD | 0.2421 | <0.001 |
MDMA | 0.2160 | <0.001 |
Phencyclidine | 0.1819 | 0.006 |
Ketamine | −0.0623 | 0.420 |
Mescaline | −0.0233 | 0.744 |
Psilocybin | −0.1676 | 0.030 |
Ayahuasca | 0.1273 | 0.171 |
DOB | −0.1165 | 0.245 |
DXM | −0.2302 | 0.005 |
Ergine | −0.2261 | 0.005 |
Methamphet. | 0.0338 | 0.643 |
Salvinorin A | 0.0588 | 0.455 |
Dronabinol | −0.0855 | 0.281 |
Ibogaine | 0.0360 | 0.507 |
2C-B-FLY | 0.0128 | 0.808 |
Nabilone | −0.0596 | 0.285 |
AL-LAD | −0.0944 | 0.183 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Al-Imam, A.; Motyka, M.A.; Witulska, Z.; Younus, M.; Michalak, M. Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland. Int. J. Environ. Res. Public Health 2022, 19, 6619. https://doi.org/10.3390/ijerph19116619
Al-Imam A, Motyka MA, Witulska Z, Younus M, Michalak M. Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland. International Journal of Environmental Research and Public Health. 2022; 19(11):6619. https://doi.org/10.3390/ijerph19116619
Chicago/Turabian StyleAl-Imam, Ahmed, Marek A. Motyka, Zuzanna Witulska, Manal Younus, and Michał Michalak. 2022. "Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland" International Journal of Environmental Research and Public Health 19, no. 11: 6619. https://doi.org/10.3390/ijerph19116619
APA StyleAl-Imam, A., Motyka, M. A., Witulska, Z., Younus, M., & Michalak, M. (2022). Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland. International Journal of Environmental Research and Public Health, 19(11), 6619. https://doi.org/10.3390/ijerph19116619